Lv428
518 积分 2023-01-31 加入
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
1个月前
已完结
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target
1个月前
已完结
Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma
1个月前
已完结
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response
1个月前
已完结
Advances in improving the efficacy of anti-PD-1/PD-L1 therapy in intrahepatic cholangiocarcinoma
1个月前
已完结
Alternative splicing generates HER2 isoform diversity underlying antibody–drug conjugate resistance in breast cancer
1个月前
已完结
CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT
1个月前
已完结
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
1个月前
已完结
Sensitization of Cancers Resistant to HER2 Antibodies
1个月前
已完结
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
1个月前
已完结
皖公网安备34019202002308
